股本结构
单位：万股
| 公告日期 | 2024-03-01 | 2024-02-27 | 2024-02-27 | 2023-11-09 | 2023-11-09 | 2023-08-10 |
|---|---|---|---|---|---|---|
| 证券总股本 | 3703.14 | 3421.89 | 3421.12 | 3310.46 | 3310.41 | 2689.96 |
| 普通股本 | 3703.14 | 3421.89 | 3421.12 | 3310.46 | 3310.41 | 2689.96 |
| 优先股 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 其他 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 | 未披露 |
| 变动日期 | 2024-03-05 | 2024-02-21 | 2023-12-31 | 2023-11-03 | 2023-09-30 | 2023-06-30 |
注释：中概股证券总股本=普通股股本/
存托凭证比例
历史变动
| 公告日期 | 变动后普通股本（万股） | 变动后优先股（万股） | 变动原因 | 变动日期 |
|---|---|---|---|---|
| 2024-03-01 | 3703.14 | 未披露 |
更多>>
Common stock offered 2,812,500 shares by the company
|
2024-03-05 |
| 2024-02-27 | 3421.89 | 未披露 | 定期报告 | 2024-02-21 |
| 2024-02-27 | 3421.12 | 未披露 |
更多>>
From December 31, 2022 to December 31, 2023
Issuance of common stock upon the vesting of restricted stock units
Shares issued in connection with the employee stock purchase plan
Exercise of vested stock options
Issuance of common stock under an at-the-market sale agreement, net of issuance costs of $0.8 million
Issuance of common stock upon follow-on public offering, net of issuance costs of $6.9 million
|
2023-12-31 |
| 2023-11-09 | 3310.46 | 未披露 | 定期报告 | 2023-11-03 |
| 2023-11-09 | 3310.41 | 未披露 |
更多>>
From June 30, 2023 to September 30, 2023
Issuance of common stock upon follow-on public offering, net of issuance costs of $6,912
Exercise of vested stock options
Issuance of common stock upon the vesting of restricted stock units
|
2023-09-30 |
| 2023-08-02 | 3261.39 | 未披露 |
更多>>
Common stock offered 5,714,285 shares by the company
|
2023-08-04 |
| 2023-08-10 | 2689.96 | 未披露 |
更多>>
From March 31, 2023 to June 30, 2023
Exercise of vested stock options
Issuance of common stock upon the vesting of restricted stock units
Shares issued in connection with the employee stock purchase plan
|
2023-06-30 |
| 2023-05-09 | 2680.37 | 未披露 | 定期报告 | 2023-05-04 |
| 2023-04-26 | 2680.33 | 未披露 | 定期报告 | 2023-04-19 |
| 2023-05-09 | 2680.05 | 未披露 |
更多>>
From December 31, 2022 to March 31, 2023
Exercise of vested stock options
Issuance of common stock upon the vesting of restricted stock units
|
2023-03-31 |
| 2023-03-17 | 2673.17 | 未披露 | 定期报告 | 2023-03-09 |
| 2023-03-17 | 2672.75 | 未披露 |
更多>>
From December 31, 2021 to December 31, 2022
Issuance of common stock upon follow-on public offering, net of issuance costs of $5,280
Lapse of repurchase obligation for stock option exercises, prior to vesting
Exercise of vested stock options
Shares issued in connection with the employee stock purchase plan
Issuance of common stock upon the vesting of restricted stock units
|
2022-12-31 |
| 2022-11-09 | 2667.22 | 未披露 | 定期报告 | 2022-11-07 |
| 2022-11-09 | 2667.18 | 未披露 |
更多>>
From June 30, 2022 to September 30, 2022
Exercise of vested stock options
Lapse of repurchase obligation for stock option exercises, prior to vesting
|
2022-09-30 |
| 2022-08-11 | 2665.85 | 未披露 | 定期报告 | 2022-08-05 |
| 2022-08-11 | 2665.01 | 未披露 |
更多>>
From March 31, 2022 to June 30, 2022
Issuance of common stock upon follow-on public offering, net of issuance costs of $5,246
Shares issued in connection with the employee stock purchase plan
Exercise of vested stock options
Issuance of common stock upon the vesting of restricted stock units
Lapse of repurchase obligation for stock option exercises, prior to vesting
|
2022-06-30 |
| 2022-05-13 | 2632.77 | 未披露 | 定期报告 | 2022-05-11 |
| 2022-05-05 | 2629.87 | 未披露 |
更多>>
1.Common stock offered by 5,600,000 shares of common stock.
2.All information in this prospectus supplement related to the number of shares of common stock to be outstanding immediately after this offering is based on 20,698,737 shares of common stock outstanding as of December 31, 2021.
|
2022-05-05 |
| 2022-05-11 | 2072.77 | 未披露 | 定期报告 | 2022-05-04 |
| 2022-05-02 | 2072.73 | 未披露 | 定期报告 | 2022-04-19 |
| 2022-05-11 | 2073.11 | 未披露 |
更多>>
From December 31, 2021 to March 31, 2022
Exercise of vested stock options
Shares issued as consideration for in-license rights
|
2022-03-31 |
| 2022-03-14 | 2070.89 | 未披露 | 定期报告 | 2022-03-09 |
| 2022-03-14 | 2069.87 | 未披露 |
更多>>
From December 31, 2020 to December 31, 2021
Lapse of repurchase rights related to common stock issued pursuant to stock option exercises prior to vesting
Exercise of vested stock options
Shares issued as consideration for in-license rights
Shares issued in connection with the employee stock purchase plan
|
2021-12-31 |
| 2021-11-10 | 2067.70 | 未披露 | 定期报告 | 2021-11-04 |
| 2021-11-10 | 2067.11 | 未披露 |
更多>>
From June 30, 2021 to September 30, 2021
Lapse of repurchase rights related to common stock issued pursuant to stock option exercises prior to vesting
Exercise of vested stock options
|
2021-09-30 |
| 2021-08-05 | 2057.41 | 未披露 | 定期报告 | 2021-08-01 |
| 2021-08-05 | 2057.40 | 未披露 |
更多>>
From March 31, 2021 to June 30, 2021
Lapse of repurchase rights related to common stock issued pursuant to early exercises
Exercise of vested stock options
|
2021-06-30 |
| 2021-04-30 | 2070.39 | 未披露 | 定期报告 | 2021-04-19 |
| 2021-05-11 | 2052.45 | 未披露 |
更多>>
From December 31, 2020 to March 31, 2021
Exercise of vested stock options
Shares issued as consideration for in-license rights
|
2021-03-31 |
| 2021-03-31 | 2050.31 | 未披露 | 定期报告 | 2021-03-19 |
| 2021-03-31 | 2032.32 | 未披露 |
更多>>
from December 31, 2019 to December 31, 2020
Issuance of Series C Preferred Stock in September 2020 at $14.0003 per share, net of issuance costs of $243
Conversion of preferred stock into common stock upon initial public offering
Lapse of repurchase rights related to common stock issued pursuant to early exercises
Issuance of common stock upon exercise of vested stock options
Shares issued as consideration for in-license rights
Issuance of common stock upon initial public offering, net of issuance costs of $2,442
|
2020-12-31 |
| 2020-11-25 | 2032.04 | 未披露 | 定期报告 | 2020-11-23 |
| 2020-10-16 | 1925.90 | 未披露 |
更多>>
1.Shares of common stock offered by the company 5,500,000 shares
2.The number of shares of common stock to be outstanding after this offering is based on 13,759,014 shares of common stock outstanding as of June 30, 2020
|
2020-10-16 |
Common stock offered 2,812,500 shares by the company
From December 31, 2022 to December 31, 2023
Issuance of common stock upon the vesting of restricted stock units
Shares issued in connection with the employee stock purchase plan
Exercise of vested stock options
Issuance of common stock under an at-the-market sale agreement, net of issuance costs of $0.8 million
Issuance of common stock upon follow-on public offering, net of issuance costs of $6.9 million
From June 30, 2023 to September 30, 2023
Issuance of common stock upon follow-on public offering, net of issuance costs of $6,912
Exercise of vested stock options
Issuance of common stock upon the vesting of restricted stock units
Common stock offered 5,714,285 shares by the company
From March 31, 2023 to June 30, 2023
Exercise of vested stock options
Issuance of common stock upon the vesting of restricted stock units
Shares issued in connection with the employee stock purchase plan
From December 31, 2022 to March 31, 2023
Exercise of vested stock options
Issuance of common stock upon the vesting of restricted stock units
From December 31, 2021 to December 31, 2022
Issuance of common stock upon follow-on public offering, net of issuance costs of $5,280
Lapse of repurchase obligation for stock option exercises, prior to vesting
Exercise of vested stock options
Shares issued in connection with the employee stock purchase plan
Issuance of common stock upon the vesting of restricted stock units
From June 30, 2022 to September 30, 2022
Exercise of vested stock options
Lapse of repurchase obligation for stock option exercises, prior to vesting
From March 31, 2022 to June 30, 2022
Issuance of common stock upon follow-on public offering, net of issuance costs of $5,246
Shares issued in connection with the employee stock purchase plan
Exercise of vested stock options
Issuance of common stock upon the vesting of restricted stock units
Lapse of repurchase obligation for stock option exercises, prior to vesting
1.Common stock offered by 5,600,000 shares of common stock.
2.All information in this prospectus supplement related to the number of shares of common stock to be outstanding immediately after this offering is based on 20,698,737 shares of common stock outstanding as of December 31, 2021.
From December 31, 2021 to March 31, 2022
Exercise of vested stock options
Shares issued as consideration for in-license rights
From December 31, 2020 to December 31, 2021
Lapse of repurchase rights related to common stock issued pursuant to stock option exercises prior to vesting
Exercise of vested stock options
Shares issued as consideration for in-license rights
Shares issued in connection with the employee stock purchase plan
From June 30, 2021 to September 30, 2021
Lapse of repurchase rights related to common stock issued pursuant to stock option exercises prior to vesting
Exercise of vested stock options
From March 31, 2021 to June 30, 2021
Lapse of repurchase rights related to common stock issued pursuant to early exercises
Exercise of vested stock options
From December 31, 2020 to March 31, 2021
Exercise of vested stock options
Shares issued as consideration for in-license rights
from December 31, 2019 to December 31, 2020
Issuance of Series C Preferred Stock in September 2020 at $14.0003 per share, net of issuance costs of $243
Conversion of preferred stock into common stock upon initial public offering
Lapse of repurchase rights related to common stock issued pursuant to early exercises
Issuance of common stock upon exercise of vested stock options
Shares issued as consideration for in-license rights
Issuance of common stock upon initial public offering, net of issuance costs of $2,442
1.Shares of common stock offered by the company 5,500,000 shares
2.The number of shares of common stock to be outstanding after this offering is based on 13,759,014 shares of common stock outstanding as of June 30, 2020